Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Discordant Commercial, Next-Gen Tumor Profiling Results May be Clinically Relevant
...
Register
Revised Travel Ban Issued
From - Laboratory Industry Report
We recently outlined the major effects and the steps you can take to manage the impact of the travel ban executive order…
What Not to Do: Customized Test Panels
From - G2 Compliance Advisor
We invite you to test your compliance expertise with a new feature in G2 Compliance Advisor. See if you can identify what the laboratory did wrong in the following…
Blood-based, Proteomic Test May ID Preterm Delivery Risk, Saving Infant Lives, Costs
...
Register
Dx Investments Hold Steady in 2016, Number of Exits Declines
...
Register
Study Reveals Resistance to Change in Cervical Cancer Screenings
From - Diagnostic Testing & Emerging Technologies
The majority of women are willing to undergo less frequent cervical cancer screening, consistent with screening guidelines, if it was…
LABcast: Uncover New Savings: Lower Shipping Costs and Heighten Logistics Support
Handout: Uncovering New Savings Presenter: Jonathan Kernya, Director of Customer Operations, OptiFreight® Logistics LABcast sponsored webinar: Uncover New Savings: Lower Shipping Costs and Heighten Logistics Support Watch, free of charge, and uncover new savings:...
OIG Fraud Alert Warns of Hotline Scammers
From - National Intelligence Report
The OIG issued a Fraud Alert recently—but it didn't warn about improper referral arrangements or billing for medically unnecessary testing. It was a warning that scammers are representing themselves as…
Alert Emphasizes Leadership Sets Tone for Safety and Quality
From - G2 Compliance Advisor
"Tone at the top" is a frequent refrain in compliance. It's also the message of a Sentinel Event Alert (Alert) issued March 1 by The Joint Commission. According to the…
Veracyte Announces Big Developments
From - Laboratory Industry Report
Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew…